Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

This was the stock's second consecutive day of losses.

Shares of Humana Inc. rallied 3.94% to $247.34 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.09% to 5,963.60 and the Dow ...

Humana Inc.’s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something of a heads-up on ...

Furthermore, Humana continues to face pressure from rising medical costs, and its benefits expense ratio increased by 270 bps y-o-y to 89%, weighing on its stock performance. Our detailed analysis ...

Humana (NYSE:HUM ... by a significant 13% over the last month. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to study its ...

Shares of Humana (HUM) are plummeting after the company ... and discuss how the rating is weighing on the health insurer's stock performance. For more expert insight and the latest market action ...

Sarah James, a stock analyst with Cantor Fitzgerald ... The lower rating won’t affect Humana’s performance until 2026, but the company said it was “disappointed with its performance and ...

Humana stock closed at $246.49 ... The company said it also is focused on improving its performance to regain its star rating. Humana, one of the biggest providers of Medicare Advantage coverage ...

The company said it is disappointed in its performance ... “Humana Plunges as Medicare Quality Rating Drop Threatens Revenue.” Watch These UnitedHealth Price Levels as Stock Extends Slide ...

Humana stock touches 52-week low at $298.59 amid market shifts ...

Humana (HUM) stock is plunging in Wednesday's session ... Sign up "The decline in Stars performance for 2025 will impact Humana's quality bonus payments in 2026," Humana said in the filing.